Luigi A. van Riel M.D.,1 Rob A. van Kollenburg M.D.,1 Remko Zweije,1 Hans Crezee,1 Theo M. de Reijke M.D.,1 Jorg R. Oddens M.D.,1 Ton G. van Leeuwen,1 Martijn de Bruinhttps://orcid.org/0000-0003-3047-36371
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Transperineal laser ablation (TPLA) treatment of prostate cancer allows for a minimal invasive treatment approach. However, a predictive dosimetry model for accurate treatment planning for prostate cancer is not yet available. Therefore, we simulated TPLA treatments on porcine liver and quantitatively evaluated thermal distribution and histology slides were made. Hereby, we determined the cumulative equivalent thermal isoeffect dose at 43°C (CEM43) that predicts cell death and led to the development of a dosimetry model.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Luigi A. van Riel M.D., Rob A. van Kollenburg M.D., Remko Zweije, Hans Crezee, Theo M. de Reijke M.D., Jorg R. Oddens M.D., Ton G. van Leeuwen, Martijn de Bruin, "Simulation of clinical focal laser ablation treatments to create a dosimetry model of the ablation zone using critical CEM43 values," Proc. SPIE 11619, Advanced Photonics in Urology, 1161906 (5 March 2021); https://doi.org/10.1117/12.2582697